Inventor · disambiguated record
Thomas Eissing
Also filed as: EISSING THOMAS
0 granted patents·3 pending applications·0 citations·filing 2017–2025
Files withBAYER AG3
Top patents by PatentIndex Score
3 records- 0172US2025302811A1Method of preventing or treating heart failure in a patient using (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamideBAYER AG·Filed 2025·Application pending·0 cites
- 0266US2025313559A1Method of preventing or treating heart failure in a patient using (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamideBAYER AG·Filed 2025·Application pending·0 cites
- 0339US2017326081A1Genotype- or phenotype-based drug formulationBAYER AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Eissing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →